Kutatási jelek – Signal Engine

• Summary of the 20th Annual MCC Multi-Center Interest Group (MMIG) - Merkel Cell Carcinoma — Merkel cell carcinoma
• Trial Results Show Majority of Patients With CLL Achieve uMRD With VenO — Chronic lymphocytic leukemia
• PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial — Colorectal cancer
• Studying the Impact of Tp53 Mutations on Colorectal Cancer Pathogenesis and Therapeutic Response in a Tunisian Population — Colorectal cancer
• From Benign Growth to Pancreatic Cancer: New Study Shows How the Switch Gets Flipped — Pancreatic cancer
• When cancer hides its origins: unique insights from Barrett's esophagus and esophageal adenocarcinoma — Esophageal cancer
• Pragmatica-Lung: A Prospective Randomized Study of Ramucirumab Plus Pembrolizumab Versus Standard of Care for Participants Previously Treated With Immunotherapy for Stage IV or Recurrent Non‑Small Cell Lung Cancer — NSCLC
• AbbVie's Elahere succeeds in Phase II platinum-sensitive ovarian cancer trial — Ovarian cancer
• SGO 2026 Preview: Evolving Standards in Cervical Cancer Screening, Prevention, and Treatment — Cervical cancer
• Trogenix announces publication of breakthrough pre-clinical data in Nature demonstrating complete tumour eradication and durable protection in aggressive brain cancer model — Glioblastoma
• Leukemia study restores silenced gene in mice. Could it point to new treatments for humans? — SCLC
• Cancer-Type Specific Prognostic Impact of Concurrent TP53 and KRAS Alterations: A Multi-Cohort Genomic Analysis — NSCLC
• Tumor Suppressor Genes in Prostate Cancer – Currently Prognostic, but Soon to Be Predictive? — Prostate cancer
• Langerhans cell histiocytosis mimicking trauma in a 2-year-old patient with T-cell acute lymphoblastic leukemia — a case report — Acute lymphoblastic leukemia
• Clinical Trial Hopes to Boost Survival Rates with Personalized Treatment for Extensive-Stage Small Cell Lung Cancer — SCLC
• Blast Phase of Chronic Myeloid Leukemia (CML) — Chronic myeloid leukemia
• Swedish study: HPV vaccines protect against cervical cancer after 18 years — Cervical cancer
• Resistance Mechanisms in EGFR-Mutated Lung Cancer Post-Treatment — NSCLC
• Nanomedicine-enabled epigenetic therapy for glioblastoma: Overcome the blood-brain barrier and therapeutic resistance — Glioblastoma
• Newly approved head and neck cancer treatment improves care for first time in more than 20 years — Head and neck squamous cell carcinoma